Scarica l'app Stockscreener
12.75
0.82%
0.0825
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
[144] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro, Inc.: ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - FinanzNachrichten.de
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Director Of ClearPoint Neuro Sold 25% Of Their Shares - simplywall.st
ClearPoint Neuro plans entry into focused ultrasound market - Investing.com UK
ClearPoint Neuro plans entry into focused ultrasound market By Investing.com - Investing.com Nigeria
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Scott Coop
Understanding Momentum Shifts in (CLPT) - Stock Traders Daily
Brain ultrasound deal tests drug delivery across blood-brain barrier - Stock Titan
How The ClearPoint Neuro (CLPT) Narrative Is Shifting On Partnerships Valuation And FDA Risks - Yahoo Finance
ClearPoint Neuro (CLPT) director receives grant of 12,820 RSUs - Stock Titan
ClearPoint Neuro (CLPT) director receives 12,820 restricted stock units in equity grant - Stock Titan
Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units - Stock Titan
Director at ClearPoint Neuro (NASDAQ: CLPT) awarded 12,820 RSUs - Stock Titan
Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units grant - Stock Titan
ClearPoint Neuro Shareholders Approve Incentive Plan and Directors - The Globe and Mail
CLPT Stock Price, Quote & Chart | CLEARPOINT NEURO INC (NASDAQ:CLPT) - ChartMill
Director Matthew Klein of ClearPoint Neuro (CLPT) receives 12,417 shares from RSU vesting - Stock Titan
Tax sale by ClearPoint (CLPT) director after RSU vesting - Stock Titan
Director at ClearPoint Neuro (NASDAQ: CLPT) gains 12,417 shares via RSU vesting - Stock Titan
ClearPoint Neuro (CLPT) investors approve directors, pay and updated incentive plan - Stock Titan
ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common shares - Stock Titan
ClearPoint Neuro (CLPT) director settles 12,417 RSUs into common stock - Stock Titan
Director Pascal Girin converts 12,417 RSUs into ClearPoint Neuro (CLPT) common shares - Stock Titan
ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common stock holdings - Stock Titan
16,000-share sale by CLPT (NASDAQ: CLPT) from vested restricted plan - Stock Titan
ClearPoint Neuro Earnings Call Signals Growth With Strain - TipRanks
Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN
ClearPoint Neuro Inc (CLPT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth By GuruFocus - Investing.com Canada
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
Avoiding Lag: Real-Time Signals in (CLPT) Movement - Stock Traders Daily
ClearPoint Neuro stock (US18507C1099): MAK Capital discloses 6.3% passive stake in CLPT - AD HOC NEWS
MAK Capital reports 6.3% stake in ClearPoint Neuro (CLPT) via Schedule 13G/A - Stock Titan
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint - ACCESS Newswire
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2026 Earnings Call Transcript - Insider Monkey
Stifel reiterates Clearpoint Neuro stock Buy rating after Q1 beat - Investing.com UK
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Stifel reiterates Clearpoint Neuro stock Buy rating after Q1 beat By Investing.com - Investing.com Nigeria
ClearPoint Neuro stock (US18507C1099): Q1 revenue surges 43% to $12.1M - AD HOC NEWS
ClearPoint Neuro Inc.Common Stock (NQ: CLPT - FinancialContent
ClearPoint Neuro, Inc. Q1 2026 earnings preview - MSN
ClearPoint Neuro (CLPT) Reports Record Q1 Revenue of $12.1 Milli - GuruFocus
ClearPoint Neuro Secures CE Marking for Surgical Drill System - Moomoo
ClearPoint forecasts $52m-$56m 2026 revenue range as IRRAflow could be cash neutral as early as 2027 - MSN
ClearPoint Neuro surgical drill receives CE Mark approval - Investing.com UK
Is ClearPoint Neuro (CLPT) 14.8% Undervalued After Q1 2026? EPS - GuruFocus
CLPT Targets Reduced Cash Burn Post-IRRAS Acquisition - GuruFocus
ClearPoint Neuro Q1 Earnings Call Highlights - sharewise.com
ClearPoint Neuro, Inc. (CLPT) reports Q1 loss, lags revenue estimates - MSN
ClearPoint Neuro (CLPT) Gains CE Mark for New Surgical Drill Sys - GuruFocus
CLPT Reports Strong Q1 Revenue Growth in Neurosurgery Sector - GuruFocus
ClearPoint Neuro Q1 earnings call highlights - MSN
0.19%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):